A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union-Reference-Cited by-同舟云学术

A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union

Published:2021-11-03 Issue:2 Volume:111 Page:470-476
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Paixão Paulo¹²^ORCID,Guerreiro Rita Bento¹,Silva Nuno¹^ORCID,Blake Kevin³,Bonelli Milton³,Morais Jose Augusto Guimarães¹,Garcia Arieta Alfredo²⁴^ORCID,Gouveia Luis Filipe¹^ORCID

Affiliation:

1. Research Institute for Medicines Faculty of Pharmacy University of Lisbon Lisbon Portugal

2. European Medicines Agency’s Pharmacokinetics Working Party Amsterdam The Netherlands

3. European Medicines Agency Amsterdam The Netherlands

4. The Spanish Agency of Medicines and Medical Devices Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2451

Reference22 articles.

1. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide

2. Generic immunosuppression in solid organ transplantation: systematic review and meta‐analysis;Molnar A.O.;BMJ

3. Therapeutic challenges in the application of serum thyroid stimulating hormone testing in the management of patients with hypothyroidism on replacement thyroid hormone therapy: a review

4. Evaluating Within‐Subject Variability for Narrow Therapeutic Index Drugs

5. What are narrow therapeutic index drugs?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union;Pharmaceutics;2024-04-28

2. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference;European Journal of Pharmaceutical Sciences;2023-11

3. Lebanese pharmacists’ knowledge of generic drugs and factors affecting their use and selection following the pandemic and the economic crisis: A pilot cross-sectional study;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2023-09-06

4. Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union;Pharmaceutics;2022-10-31

5. Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution;Healthcare;2022-07-26